Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing Agreement

Cell Therapeutics

today announced that CTI has received the remaining $5 million from Hercules Technology Growth Capital, Inc.

available under the existing loan agreement that was established in March 2013.  Further information with respect to this loan with Hercules will be available in a Current Report on Form 8-K that will be filed by CTI with the Securities and Exchange Commission.